Claims for Patent: 5,902,844

Summary for Patent: 5,902,844

Title:	Spray drying of pharmaceutical formulations containing amino acid-based materials
Abstract:	Methods of forming solid pharmaceutical compositions comprise solubilizing water-soluble polymers and amino acid-based components having molecular weights ranging from about 100 daltons to about 200,000 daltons or pharmaceutically acceptable salts thereof in solvents; and separating the solvents from the water-soluble polymers and the amino acid-based components or pharmaceutically acceptable salts thereof to form solid pharmaceutical compositions comprising the water-soluble polymers and the amino acid-based components or pharmaceutically acceptable salts thereof.
Inventor(s):	Wilson; Edward S. (Wilmington, NC)
Assignee:	Applied Analytical Industries, Inc. (Wilmington, NC)
Application Number:	09/017,512
Patent Claims:	1. A method of forming a solid pharmaceutical composition, said method comprising: solubilizing at least one water-soluble polymer and at least one amino acid-based containing component having a molecular weight ranging from about 100 daltons to about 200,000 daltons, or a pharmaceutically acceptable salt thereof, in an aqueous solvent to form a solubilized mixture; and separating the aqueous solvent from the at least one water-soluble polymer and the at least one amino acid-containing component, or pharmaceutically acceptable salt thereof, to form a solid pharmaceutical composition comprising the at least one water-soluble polymer and the at least one amino acid-containing component or pharmaceutically acceptable salt thereof. 2. The method according to claim 1, wherein the solvent is selected from the group consisting of water and an alcohol/water mixture. 3. The method according to claim 1, wherein the at least one amino acid-based component component is selected from the group consisting of gonadorelin acetate, chorinic gonadotropin, somatropin, altepase, calcitonic, somatostatin, vasopressin, glucagon, menotropins, urofollitropin, somatoprem, .alpha.-galactosidase, .beta.-galactosidase, and mixtures thereof. 4. The method according to claim 1, wherein said step of separating the solvent from the at least one water-soluble polymer and the at least one amino acid-based component or pharmaceutically acceptable salt thereof comprises: dispersing the solubilized mixture; and exposing the solubilized mixture to a gaseous stream such that the solvent separates from the at least one amino acid-based component or pharmaceutically acceptable salt thereof and the at least one water-soluble polymer. 5. The method according to claim 4, wherein the gaseous stream is present at a temperature ranging from about 20.degree. C. to about 140.degree. C. 6. The method according to claim 4, wherein the gaseous stream comprises a component selected from the group consisting of air, nitrogen, argon, and mixtures thereof. 7. The method according to claim 1, wherein the at least one water-soluble polymer is selected from the group consisting of poly(vinylpyrrolidone), hydroxypropyl methylcellulose, hydroxypropyl cellulose, carbomer, alginates, colloidal magnesium aluminum silicates, ethyl cellulose, polyethylene oxides, and mixtures thereof. 8. The method according to claim 7, wherein the solvent is selected from the group consisting of water and an alcohol/water mixture. 9. The method according to claim 8, wherein the at least one amino acid-based component component is selected from the group consisting of gonadorelin acetate, chorinic gonadotropin, somatropin, altepase, calcitonic, somatostatin, vasopressin, glucagon, menotropins, urofollitropin, somatoprem, .alpha.-galactosidase, .beta.-galactosidase, and mixtures thereof. 10. The method according to claim 9, wherein said step of separating the solvent from the at least one water-soluble polymer and the at least one amino acid-based component or pharmaceutically acceptable salt thereof comprises: dispersing the solubilized mixture; and exposing the solubilized mixture to a gaseous stream such that the solvent separates from the at least one amino acid-based component or pharmaceutically acceptable salt thereof and the at least one water-soluble polymer. 11. The method according to claim 10, wherein the gaseous stream is present at a temperature ranging from about 20.degree. C. to about 140.degree. C. 12. The method according to claim 11, wherein the gaseous stream comprises a component selected from the group consisting of air, nitrogen, argon, and mixtures thereof.

Details for Patent 5,902,844

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Emd Serono, Inc.	PERGONAL	menotropins	For Injection	017646	August 22, 1975		2018-02-02
Emd Serono, Inc.	PERGONAL	menotropins	For Injection	017646	May 20, 1985		2018-02-02
Eli Lilly And Company	HUMATROPE	somatropin	For Injection	019640	June 23, 1987		2018-02-02
Eli Lilly And Company	HUMATROPE	somatropin	For Injection	019640	October 16, 1986		2018-02-02